PNTG
The Pennant Group, Inc. · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth +20.0% ·
share flow -12.4% ·
net new positions +16.7%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | +2 | 17.44M | $643.59M | +9 | −6 |
| Q1 2026 | 82 | +1 | 17.11M | $521.38M | +4 | −3 |
| Q4 2025 | 81 | +1 | 18.52M | $521.75M | +2 | −1 |
| Q3 2025 | 19 | 0 | 10.21M | $257.46M | +1 | −1 |
| Q2 2025 | 16 | -1 | 11.14M | $332.63M | +1 | −2 |
| Q1 2025 | 14 | +3 | 2.52M | $63.50M | +3 | — |
| Q4 2024 | 11 | -2 | 2.73M | $72.43M | +1 | −3 |
| Q3 2024 | 12 | +2 | 1.68M | $60.08M | +2 | — |
| Q2 2024 | 10 | — | 1.92M | $44.57M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 682.13K | +0.4% | $24.36M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 682.13K | +0.4% | $24.36M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Arrowstreet Capital ✦ | 331.66K | +57.4% | $11.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 293.24K | -27.7% | $10.47M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 138.40K | -48.2% | $4.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 56.63K | -39.5% | $2.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 52.88K | -34.4% | $1.89M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 42.10K | +8.3% | $1.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 35.83K | -33.8% | $1.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 35.83K | -33.8% | $1.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 19.20K | New | $685,440 | 0.0% | New | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 13.22K | -81.8% | $471,954 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Marshall Wace ✦ | 9.72K | New | $346,898 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 7.67K | -60.3% | $273,998 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 7.67K | -60.3% | $273,998 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 7.67K | -60.3% | $273,998 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $685,440 | 0.0% |
| Marshall Wace | $346,898 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 182 holders, 28.77M shares, $793.32M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.39K sh · $53,661
Officer · 4.29K sh · $165,067
Officer · 1.39K sh · $53,700
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology